For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment. Heather Quintana Suchan, a ...

Rebecca Chacko, MD, discussed exciting advancements in breast cancer care and the future role of emerging therapeutic strategies for early recurrence detection, as part of her panelist role at the ...

There is a great need to streamline the process from the tissue sample to the diagnostic lab, whether it's genomic or immunohistochemistry, Robert Kratzke, MD, says. Delays in genomic testing continue ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

Lung cancer in never-smokers challenges lifestyle-based assumptions and underscores the need to address stigma that can delay evaluation and psychosocial support. Subtle, prolonged respiratory or ...

For patients with challenging cancers like lymphoma and sarcoma, these 3D images dramatically change the way doctors diagnose ...

Researchers compared clinicopathologic features, MammaPrint and BluePrint molecular subtype, and outcomes by race among patients with HR+, HER2− early-stage breast cancer.

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast ...

New Zealanders with cancer and rare disorders will benefit from faster, locally delivered genomic testing through a new ...